Healthcare Equipment & Supplies / Medical Glove Manufacturing
Strategic Profile
The company is headquartered in Malaysia with manufacturing facilities in Malaysia, Thailand and the PRC, with approximately 51 factories, out of which 45 are in Malaysia, five in Thailand, and one in Vietnam. The overall consensus recommendation for Top Glove is Hold, with the stock trading significantly below analyst valuation targets as of early 2026.
Cyborg Score Rationale
The stock has declined 51.81% over the past 365 days and underperformed the FTSE Developed Asia Pacific Index by -64.88% over the past year. While the company maintains market leadership in a global industry, investor sentiment remains cautious with analyst consensus at 'Hold' despite significant upside potential in pricing targets.
Top Insights
Current share price represents 234.7% upside potential to consensus target
Operates 51 manufacturing facilities globally with significant Malaysia-based concentration
Dividend yield of 0.76%
Recent warrant conversion and bonus warrant issue indicate capital structure optimization activities
Named Competitors
Examination Gloves — Malaysian glove manufacturers competing in medical and examination glove segments
Nitrile Glove Production — Various regional manufacturers competing on cost and capacity in Asia
Recent Developments
(December 2025) Released FY2025 audited financial statements for year ended August 31, 2025